Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Connecting Doctors and NGOs to empower medical missions and humanitarian work worldwide.
      
      Learn more
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Payors
  - Healthcare Professionals
- - Featured
  - - Empowering Medical and Commercial Teams with Data Insights
      
      In Conversation with Katie Shin, Sr. Global Director of Field Medical and Scientific Affairs, Sumitomo Pharma America
      
      Learn More
Customers
Resources
Company
- - What’s New
  - Press
  - Events
  - Get in Touch
  - Contact Us
- - Featured Press
  - - H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards
      
      Learn More
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

Global Impact

HCP Volunteers

KOL Engagement

Provider Data

Research

Post Industries:

Commercialization

Global Impact

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

KOL Engagement
KOL to Go? The Modern MSL & Mobile Apps
As the pharmaceutical industry becomes increasingly competitive, speed and efficiency are crucial for getting drugs to market faster. This is where mobile apps come in. And at the heart of… Continue reading →

Read the article
no
KOL Engagement
From Academia to Patients: The Evolution of MSL Territories
As the role of the Medical Science Liaison (MSL) has evolved from academic rigor to understanding disease trends, a key component of MSL territory planning is collaboration with Key… Continue reading →

Read the article
no
Artificial Intelligence Commercialization Diversity & Inclusion Drug Development
7 Ways of Generating AI-produced ROI for Life Sciences
For life sciences companies, the application of AI has the potential to provide transformative value, not only in terms of direct financial return but also through operational, research, and clinical… Continue reading →

Read the article
no
Diversity & Inclusion Drug Development
The Trust Fall: Building Successful & Diverse Trials Outside the U.S.
As the U.S. ramps up for release of the latest COVID-19 vaccine booster, the Centers for Disease Control and Prevention (CDC) recommends that all Americans aged 6 months and… Continue reading →

Read the article
no
Drug Development
4 Ways CROs Can Ensure a Bright Future for Pharma
As pharmaceutical companies turn to CROs (Clinical Research Organizations) for trial design and technology, there are new opportunities emerging with healthcare data intelligence that can help ensure a bright future… Continue reading →

Read the article
no
Artificial Intelligence
AI for Hire: 5 Considerations for AI Innovation Workforce Strategies
At every industry conference this fall, half of the sessions will likely be focused on artificial intelligence (AI) and how important it is. The challenge is in knowing how AI… Continue reading →

Read the article
no

‹1 234 5 6 ›»

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
H1 Connect

About

About H1
Culture
Press
Events
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2024 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape

Don't have an account? Request a demo.

✕